NEW YORK (GenomeWeb News) - Molecular Devices’ shares surged 47 percent in afternoon trading to $35.05 from Friday’s close of $23.38, in the wake of this morning’s announcement that the company will be bought by MDS.
MDS said earlier today that it will pay $615 million in cash for Molecular Devices and combine the firm with its MDS Sciex business.
MDS’ stock was up 1.17 percent to $17.30.
Registering provides access to this and other free content.
Already have an account?Login Now.
The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.
Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.
Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.
In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.